Differential Protein and Gene Expression in Endocrine and Neuroendocrine Tumors (NET)

Differential Protein and Gene Expression in Endocrine and Neuroendocrine Tumors (NET) - Molecular pathology in NET

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010117

Enrollment

1000

Registered

2016-03-14

Start date

2016-02-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C17 D44 C75 C25.4 D35

Interventions

Group 1: Quantitative Expression Analysis of the proteom and gene Expression of Primary Tumor, normal tissue, and metastases

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent surgery due to (neuro)endocrine tumors

Exclusion criteria

Exclusion criteria: //

Design outcomes

Primary

Measure	Time frame
Disease associated Proteins and Genes	—

Secondary

Measure	Time frame
Identification of markers with prognostic significance	—

Countries

Germany

Contacts

Public ContactThomas J. Musholt

Universitätsmedizin Mainz, Sektion Endokrine Chirurgie, Klinik für Allgemein-, Viszeral- u. Transplantationschirurgie

musholt@uni-mainz.de06131 17-5117

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026